Requirements for Patent Applications Containing Nucleotide Sequence and/or Amino Acid Sequence Disclosures

ICR 202303-0651-019

OMB: 0651-0024

Federal Form Document

Forms and Documents

Document Name	Status
Unleashing American Innovators Act of 2022.pdf Supplementary Document	2023-03-24
Unleashing American Innovators Act of 2022.pdf Supplementary Document	2023-03-24
0651-0024 2023 Patent Fee CWS 2023.docx Justification for No Material/Nonsubstantive Change	2023-03-24
0651-0024 2023 Patent Fee CWS 2023.docx Justification for No Material/Nonsubstantive Change	2023-03-24
0651-0024 Supporting Statement 2022.docx Supporting Statement A	2022-09-16
0651-0024 Supporting Statement 2022.docx Supporting Statement A	2022-09-16
Patent Cooperation Treaty.pdf Supplementary Document	2022-09-16
Patent Cooperation Treaty.pdf Supplementary Document	2022-09-16
Leahy Smith America Invents Act.pdf Supplementary Document	2022-09-16
Leahy Smith America Invents Act.pdf Supplementary Document	2022-09-16
Information Quality Guidelines _ USPTO.html Supplementary Document	2022-05-20
Information Quality Guidelines _ USPTO.html Supplementary Document	2022-05-20

IC Document Collections

IC ID	Document Title	Status
45201	Sequence Listing in Application (Private Sector)	Modified
45200	Sequence Listing in Application (Individuals and Households)	Unchanged